Atriance - Product Overview Oncology GSK Pharma UK Healthcare Professionals (nelarabine)
Clicks:38, Listing added: Feb 4, 2013
|
|
|
:
Atriance (nelarabine) is indicated for the treatment of patients with T-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least 2 chemoth
0.0 (0)
1
2
3
4
5